Decision Support · Side-by-side

Arctoris vs Exscientia. Side by side.

Compare pricing, strengths, and use cases so it is easier to pick the right fit.

Browse alternatives Browse workflows

Change tools

Comparison Ready

Arctoris

Exscientia

Best overall

Neither Arctoris nor Exscientia is for everyday users — both are enterprise-grade drug discovery platforms for professional scientists. Arctoris wins for labs that need reproducible robotic experimentation, while Exscientia wins for organizations that want AI-designed molecules ready for clinical trials. The single biggest difference: Arctoris automates the physical lab work, Exscientia focuses on computational molecular design.

Arctoris

#4657 of 3,826 Web

Exscientia

#4220 of 3,826 Web

Scores at a glance

ArctorisExscientiaPractical Versatility

Onboarding Ease

Ecosystem Fit

Market Value

Choose Arctoris if

You run a biotech lab that needs to automate thousands of repetitive experiments per week
You prioritize data reproducibility and want every environmental variable logged
You have a budget for robotic services and can ship compounds to a central hub
You are a pharmaceutical company looking to integrate AI with physical lab automation

Choose Exscientia if

You are a large pharmaceutical company wanting AI-designed drug candidates ready for human trials
You have patient tissue data and want to use it to design more targeted therapies
You need end-to-end drug discovery from target identification through clinical trial design
You can commit to a multi-million dollar partnership and a long onboarding process

Key differences

Arctoris automates physical lab experiments; Exscientia designs molecules computationally
Exscientia has a proven track record with AI molecules in human trials; Arctoris focuses on lab reproducibility
Arctoris requires shipping compounds to a robotic hub; Exscientia works with your data remotely
Both lack mobile apps and public APIs — neither is usable on a phone
Exscientia uses patient tissue data; Arctoris uses standard chemical and protein inputs
Both have unpublished pricing and high entry barriers, but Exscientia targets larger pharma partners

Facts side by side

	Arctoris	Exscientia
Free plan
Mobile app
API access

Arctoris: strengths & weaknesses

Robots handle repetitive lab tasks so scientists can focus on analysis
Every experiment is logged with full metadata, making results reproducible
Works with standard chemical inputs like SMILES and CSV files
No mobile app or public API — you can't use it on your phone
Requires shipping physical compounds to their robotic hub, limiting geographic access
Initial setup is complex and needs a scientific consultation before you get any value
Pricing is unpublished and likely too expensive for small labs or individuals

Exscientia: strengths & weaknesses

First company to get AI-designed molecules into human clinical trials — proven track record
Uses real patient tissue data to design drugs, not just computer models
End-to-end from target identification to clinical trial design
No mobile app, no API, no self-service — you need a partnership deal to access it
Algorithms are proprietary and opaque — you can't see how decisions are made
Extremely high cost; only large pharma or well-funded biotechs can afford it
Not available for individual researchers or small startups

Common questions

Can I use Arctoris or Exscientia on my phone?

No. Neither tool has a mobile app or a mobile-friendly interface. Both are designed for professional scientists working at a desk with specialized lab equipment or data pipelines.

Which is better for a small biotech startup with limited budget?

Neither is a good fit. Both have high entry costs and complex onboarding. Arctoris might be slightly more accessible if you only need robotic assay automation, but expect significant upfront investment.

Do these tools replace human scientists?

No. Arctoris replaces repetitive manual lab work with robots, and Exscientia accelerates molecular design, but both still require expert scientists to define targets, interpret results, and make decisions.

Is Exscientia better than Arctoris for drug discovery?

It depends on your need. Exscientia is better if you want AI-designed molecules for clinical trials. Arctoris is better if you need automated, reproducible lab experiments to test many compounds quickly.

Arctoris and Exscientia are powerful but inaccessible for everyday users — both are enterprise-only drug discovery platforms with high costs, no mobile access, and complex onboarding.

If you're a non-technical person or a small business owner, neither Arctoris nor Exscientia is for you — they are specialized tools for professional drug discovery teams with big budgets. For everyday users, look at simpler AI tools like ChatGPT or Claude for text tasks, or Canva for design.

Visit Arctoris Visit Exscientia

Detail pages: Arctoris · Exscientia

Arctoris

Exscientia

Free plan

Mobile app

API access